Click the
button to view the videos in full screen
Influenza A (H1N1) Virus: Are We Ready?
LAURENE MASCOLA, M.D.
CHIEF, ACUTE COMMUNICABLE DISEASE CONTROL PROGRAM
LA COUNTY DEPARTMENT OF PUBLIC HEALTH
MODERATOR: PAOLA TEMPESTI, M.D.; CHAIR, INFECTION PREVENTION COMMITTEE
FACULTY DISCLOSURE: According to CMA guidelines for faculty disclosure of commercial support, we are required to announce the following:
Dr. Mascola states she is on the Speakers Bureau for Merck and Medimmune and consultant to the infectious disease board of Merck.
OBJECTIVES
At the end of the presentation, attendees will be able to: - identify current H1N1 “hot spots” in LA County and who is at risk for H1N1 influenza.
- recognize the signs and symptoms of HiN1.
- cite the ecommended treatment and prophylaxis modalities for H1N1and recommended infection prevention measures
- cite the roles of local, state, and federal agencies in responding to an H1N1 outbreak.
- know what to do if you suspect H1N1.
- identifycultural/linguistic factors that impact the epidemiology, incidence, diagnosis, treatment, clinical course, and/or long-term outcomes of H1N1 influenza
This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)™
|
|
9/15/2009
|
|
Laurene
Mascola,
MD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
|
|
|
|
|
|
Prevention and Treatment of Vitamin D Deficiency: Endocrinology Perspective
|
|
YAROSLAV GOFNUNG, M.D.
DEPARTMENT OF MEDICINE, PSJMC
MODERATOR: Paola Tempesti, M.D.; Department of Medicine, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following:
Dr. Gofnung states he has no disclosures. Dr. Tempesti states she has stock in Bristol Myers Squibb.
OBJECTIVES
At the end of the presentation, attendees will be able to: - identify who is at risk for Vitamin D deficiency and recognize the signs and symptoms.
- conduct an appropriate work-up for Vitamin D status and interpret results.
- incorporate into practice the latest recommendations for prevention and treatment of Vitamin D deficiency.
- identify cultural/linguistic factors that impact the epidemiology, incidence, diagnosis, treatment, clinical course, and/or long-term outcomes of Vitamin D deficiency.
This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.
|
|
|
|
|
|
American Recovery and Reinvestment Act
|
|
DOUGLAS JONES
DIR., INFORMATION SYSTEMS, PROVIDENCE HEALTH &SERVICES, CA REGION
MODERATOR: Raffi Mesrobian, MD; Vice-Chief of Staff, PSJMC
FACULTY DISCLOSURE: According to CMA guidelines for faculty/planner disclosure of commercial support, we are required to announce the following: Mr. Jones states he has no disclosures. Dr. Mesrobian states he has no disclosures.
OBJECTIVES
At the end of the presentation, attendees will be able to: - cite the provisions of the ARRA related to HIT and EMR and determine the potential impact on hospitals and physicians in California.
- discuss how physicians can best prepare for adoption of HIT and receive federal subsidy for implementation of “meaningful use” of EMR.
- determine how PH&S California Region is assisting in the HIT alignment of physician groups and hospitals.
- identifycultural/linguistic factors such as computer literacy that impact the long-term outcomes of HIT adoption.
This activity is designated for a maximum of .75 AMA PRA Category 1 Credit(s)TM.
|
|
|
|
|